Pfizer Inc SEC filings PFE
Pfizer Inc has 1,000 filings in SEC EDGAR's recent list, going back to Feb 26, 2021. Its latest annual report, Form ARS, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 27, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Nov 3, 2026 | Oct 30, 2026 |
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 27, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| N-PX | Filing | Aug 31, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 28, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 18, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 18, 2026 | Jun 18, 2026 |
| 11-K | Employee savings plan report | Jun 16, 2026 | Dec 31, 2025 |
| 11-K | Employee savings plan report | Jun 16, 2026 | Dec 31, 2025 |
| S-8 | Employee stock plan registration | May 5, 2026 | — |
| 10-Q | Quarterly report | May 5, 2026 | Mar 29, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Apr 27, 2026 | Apr 23, 2026 |
| ARS | Annual report to shareholders | Mar 12, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Mar 12, 2026 | — |
| DEF 14A | Proxy statement | Mar 12, 2026 | Apr 23, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 3, 2026 | Feb 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 16, 2025 | Dec 16, 2025 |
| 8-K |
Current report
Other events
|
Nov 21, 2025 | Nov 18, 2025 |
| 424B5 | Prospectus supplement | Nov 20, 2025 | — |
| FWP | Free writing prospectus | Nov 19, 2025 | — |
| 424B3 | Prospectus | Nov 18, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 28, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 29, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 11-K | Employee savings plan report | Jun 16, 2025 | Dec 31, 2024 |
| 11-K | Employee savings plan report | Jun 16, 2025 | Dec 31, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 30, 2025 | — |
| CERT | Nyse certification | May 20, 2025 | — |
| 8-A12B | Filing | May 19, 2025 | — |
| 8-K |
Current report
Other events
|
May 19, 2025 | May 14, 2025 |
| 424B5 | Prospectus supplement | May 15, 2025 | — |
| FWP | Free writing prospectus | May 14, 2025 | — |
| 424B3 | Prospectus | May 13, 2025 | — |
| POSASR | Filing | May 13, 2025 | — |
| 10-Q | Quarterly report | May 5, 2025 | Mar 30, 2025 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs
|
Apr 29, 2025 | Apr 29, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Apr 28, 2025 | Apr 24, 2025 |
| DEFA14A | Additional proxy material | Apr 11, 2025 | — |
| DEFA14A | Additional proxy material | Apr 10, 2025 | — |
| DEFA14A | Additional proxy material | Apr 10, 2025 | — |
| DEFA14A | Additional proxy material | Apr 10, 2025 | — |
| DEFA14A | Additional proxy material | Apr 7, 2025 | — |
| PX14A6G | Filing | Mar 25, 2025 | — |
| ARS | Annual report to shareholders | Mar 13, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Mar 13, 2025 | — |
| DEF 14A | Proxy statement | Mar 13, 2025 | Apr 24, 2025 |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 4, 2025 | Feb 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 17, 2024 | Dec 17, 2024 |
| 10-Q | Quarterly report | Nov 4, 2024 | Sep 29, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2024 | Oct 29, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2024 | Oct 10, 2024 |
| SC TO-I/A | Pfizer sc to-i/a amendment 2 final | Sep 13, 2024 | — |
| CORRESP | Letter to the SEC | Aug 22, 2024 | — |
| SC TO-I/A | Filing | Aug 22, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2024 | — |
| SC TO-I | Filing | Aug 12, 2024 | — |
| 10-Q | Quarterly report | Aug 5, 2024 | Jun 30, 2024 |
| SC TO-C | Sc to-c pre communication | Aug 1, 2024 | — |
| SC TO-C | Sc to-c pre communicatuns | Jul 30, 2024 | — |
| 8-K |
Current report
Results of operations
|
Jul 30, 2024 | Jul 30, 2024 |
| SC TO-C | Pfizer sc to-c | Jul 26, 2024 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 26, 2024 | Jul 24, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 10, 2024 | Jul 9, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 1, 2024 | Jun 27, 2024 |
| 11-K | Employee savings plan report | Jun 11, 2024 | Dec 31, 2023 |
| 11-K | Employee savings plan report | Jun 11, 2024 | Dec 31, 2023 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2024 | — |
| 8-K |
Current report
Exit or restructuring costs
|
May 22, 2024 | May 22, 2024 |
| S-8 | Employee stock plan registration | May 9, 2024 | — |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 1, 2024 | May 1, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Apr 29, 2024 | Apr 25, 2024 |
| PX14A6G | Filing | Apr 16, 2024 | — |
| DEFA14A | Additional proxy material | Apr 11, 2024 | — |
| DEFA14A | Additional proxy material | Apr 11, 2024 | — |
| DEFA14A | Additional proxy material | Apr 11, 2024 | — |
| DEFA14A | Additional proxy material | Apr 9, 2024 | — |
| DEFA14A | Additional proxy material | Mar 28, 2024 | — |
| DEFA14A | Additional proxy material | Mar 28, 2024 | — |
| ARS | Annual report to shareholders | Mar 14, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Mar 14, 2024 | — |
| DEF 14A | Proxy statement | Mar 14, 2024 | Apr 25, 2024 |
| S-3ASR | Automatic shelf registration | Feb 23, 2024 | — |
| S-8 | Employee stock plan registration | Feb 23, 2024 | — |
| 10-K | Annual report | Feb 22, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Jan 30, 2024 | Jan 30, 2024 |
| 8-K |
Current report
Other events
|
Jan 10, 2024 | Jan 10, 2024 |
| 8-K/A |
Amended current report
Acquisition or sale of assets, Regulation FD disclosure
|
Dec 14, 2023 | Dec 14, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Dec 14, 2023 | Dec 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 13, 2023 | Dec 13, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 12, 2023 | Dec 7, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Oct 1, 2023 |
| 8-K |
Current report
Results of operations
|
Oct 31, 2023 | Oct 31, 2023 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Regulation FD disclosure
|
Oct 13, 2023 | Oct 13, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jul 2, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2023 | Aug 1, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 27, 2023 | Jul 21, 2023 |
| 11-K | Employee savings plan report | Jun 20, 2023 | Dec 31, 2022 |
| 11-K | Employee savings plan report | Jun 20, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Other events
|
May 19, 2023 | May 16, 2023 |
| 424B5 | Prospectus supplement | May 18, 2023 | — |
| FWP | Free writing prospectus | May 17, 2023 | — |
| 424B3 | Prospectus | May 15, 2023 | — |
| POSASR | Filing | May 15, 2023 | — |
| 8-K |
Current report
Other events
|
May 15, 2023 | May 12, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Apr 2, 2023 |
| 8-K |
Current report
Results of operations
|
May 2, 2023 | May 2, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 1, 2023 | Apr 27, 2023 |
| PX14A6G | Filing | Apr 12, 2023 | — |
| DEFA14A | Additional proxy material | Apr 10, 2023 | — |
| DEFA14A | Additional proxy material | Apr 10, 2023 | — |
| PX14A6G | Filing | Apr 4, 2023 | — |
| DEFA14A | Additional proxy material | Mar 30, 2023 | — |
| PX14A6G | Pfizer | Mar 22, 2023 | — |
| ARS | Annual report to shareholders | Mar 17, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Mar 16, 2023 | — |
| DEF 14A | Proxy statement | Mar 16, 2023 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Mar 13, 2023 | Mar 12, 2023 |
| S-8 | Employee stock plan registration | Feb 27, 2023 | — |
| 10-K | Annual report | Feb 23, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Other events
|
Feb 21, 2023 | Feb 21, 2023 |
| 8-K |
Current report
Results of operations
|
Jan 31, 2023 | Jan 31, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 13, 2022 | Dec 9, 2022 |
| 10-Q | Quarterly report | Nov 9, 2022 | Oct 2, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2022 | Nov 1, 2022 |
| 10-Q | Quarterly report | Aug 10, 2022 | Jul 3, 2022 |
| 8-K |
Current report
Results of operations
|
Jul 28, 2022 | Jul 28, 2022 |
| 11-K | Employee savings plan report | Jun 9, 2022 | Dec 31, 2021 |
| 11-K | Employee savings plan report | Jun 9, 2022 | Dec 31, 2021 |
| 10-Q | Quarterly report | May 11, 2022 | Apr 3, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 10, 2022 | May 9, 2022 |
| 8-K |
Current report
Results of operations
|
May 3, 2022 | May 3, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 2, 2022 | Apr 28, 2022 |
| DEFA14A | Additional proxy material | Apr 22, 2022 | — |
| 8-K |
Current report
Results of operations
|
Apr 20, 2022 | Apr 20, 2022 |
| UPLOAD | Letter from the SEC | Apr 14, 2022 | — |
| PX14A6G | Filing | Apr 14, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Apr 12, 2022 | Apr 11, 2022 |
| CORRESP | Letter to the SEC | Apr 12, 2022 | — |
| DEFA14A | Additional proxy material | Apr 11, 2022 | — |
| DEFA14A | Additional proxy material | Apr 6, 2022 | — |
| DEFA14A | Additional proxy material | Mar 30, 2022 | — |
| 8-K |
Current report
Other events
|
Mar 29, 2022 | Mar 24, 2022 |
| PX14A6G | Filing | Mar 21, 2022 | — |
| PX14A6G | Filing | Mar 21, 2022 | — |
| DEFA14A | Additional proxy material | Mar 17, 2022 | — |
| DEF 14A | Proxy statement | Mar 17, 2022 | Apr 28, 2022 |
| 25-NSE | Delisting notice | Mar 7, 2022 | — |
| 10-K | Annual report | Feb 24, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 8, 2022 | Feb 8, 2022 |
| CORRESP | Letter to the SEC | Dec 23, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Dec 15, 2021 | Dec 9, 2021 |
| UPLOAD | Letter from the SEC | Dec 10, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Nov 19, 2021 | Nov 15, 2021 |
| 10-Q | Quarterly report | Nov 12, 2021 | Oct 3, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2021 | Nov 2, 2021 |
| 8-K |
Current report
Other events
|
Aug 18, 2021 | Aug 16, 2021 |
| 424B5 | Prospectus supplement | Aug 17, 2021 | — |
| FWP | Free writing prospectus | Aug 16, 2021 | — |
| 424B3 | Prospectus | Aug 16, 2021 | — |
| 10-Q | Quarterly report | Aug 12, 2021 | Jul 4, 2021 |
| 8-K |
Current report
Results of operations
|
Jul 28, 2021 | Jul 28, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 9, 2021 | Jul 6, 2021 |
| 11-K | Employee savings plan report | Jun 7, 2021 | Dec 31, 2020 |
| 11-K | Employee savings plan report | Jun 7, 2021 | Dec 31, 2020 |
| 11-K | Employee savings plan report | Jun 7, 2021 | Dec 31, 2020 |
| 10-Q | Quarterly report | May 13, 2021 | Apr 4, 2021 |
| 8-K |
Current report
Results of operations
|
May 4, 2021 | May 4, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Apr 26, 2021 | Apr 22, 2021 |
| DEFA14A | Additional proxy material | Apr 15, 2021 | — |
| DEFA14A | Additional proxy material | Mar 29, 2021 | — |
| PX14A6G | Filing | Mar 23, 2021 | — |
| PX14A6G | Filing | Mar 22, 2021 | — |
| DEFA14A | Additional proxy material | Mar 12, 2021 | — |
| DEF 14A | Proxy statement | Mar 12, 2021 | Apr 22, 2021 |
| S-3ASR | Automatic shelf registration | Feb 26, 2021 | — |
Showing 182 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PFE (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 78003
- Former names
- PFIZER INC (until Nov 3, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.